McIlrath & Eck, LLC

SEC CIK: 0001701714
Latest filing: May 19, 2026

SEC filings (opens in a new tab)

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overview All 13F holders of ALNY Full Q1 2026 holdings

Shares (Q2 2023): 0; Sold out in Q2 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q1 2023

Holdings of ALNY by McIlrath & Eck, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2023	0	$0	0.0%	−3−100.0%	Sold out	Holders
Q1 2023	3	$601	<0.1%	+3	New	Holders